Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis

Show other versions (1)

<h4>Background</h4> Snakebite envenoming (SBE) is a neglected tropical disease capable of causing both significant disability and death. The burden of SBE is especially high in low- and middle-income countries. The aim of this study was to perform a geospatial analysis evaluating the ass...

Full description

Bibliographic Details
Main Authors:	Julia Elizabeth Isaacson, Jinny Jing Ye, Lincoln Luís Silva, Thiago Augusto Hernandes Rocha, Luciano de Andrade, Joao Felipe Hermann Costa Scheidt, Fan Hui Wen, Jacqueline Sachett, Wuelton Marcelo Monteiro, Catherine Ann Staton, Joao Ricardo Nickenig Vissoci, Charles John Gerardo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-06-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284398/?tool=EBI

Similar Items

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis.
by: Julia Elizabeth Isaacson, et al.
Published: (2023-06-01)

Scaling up antivenom for snakebite envenoming in the Brazilian Amazon: a cost-effectiveness analysisResearch in context
by: Armand Zimmerman, et al.
Published: (2024-01-01)

Special issue editorial: Resource mapping for the management of snakebite envenomation
by: Wuelton M. Monteiro, et al.
Published: (2023-06-01)

Mapping of clinical management resources for snakebites and other animal envenomings in the Brazilian Amazon
by: Timothy P. Beck, et al.
Published: (2022-12-01)

Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
by: Abdulrazaq G Habib, et al.
Published: (2015-01-01)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
by: Emilie Alirol, et al.
Published: (2015-09-01)

Development and validation of a minimum requirements checklist for snakebite envenoming treatment in the Brazilian Amazonia.
by: Thiago Serrão-Pinto, et al.
Published: (2024-01-01)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
by: Muralidharan Vanuopadath, et al.
Published: (2023-08-01)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
by: Shou Terashige, et al.
Published: (2021-01-01)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
by: Asenate A. X. Adrião, et al.
Published: (2022-05-01)

A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
by: Gutiérrez, J, et al.
Published: (2014)

A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming
by: José María Gutiérrez, et al.
Published: (2014-07-01)

History of Snakebite Envenomation Treatment and Contribution of Turkey to Global Antivenom Production
by: Can Sarica, et al.
Published: (2018-12-01)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.
by: Muhammad Hamza, et al.
Published: (2016-03-01)

Validation of a Culturally Relevant Snakebite Envenomation Clinical Practice Guideline in Brazil
by: Gisele dos Santos Rocha, et al.
Published: (2022-05-01)

Children Growing Up with Severe Disabilities as a Result of Snakebite Envenomations in Indigenous Villages of the Brazilian Amazon: Three Cases and Narratives
by: Altair Seabra de Farias, et al.
Published: (2023-05-01)

Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies
by: Suthimon Thumtecho, et al.
Published: (2023-12-01)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
by: José María Gutiérrez, et al.
Published: (2021-06-01)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
by: Julien Potet, et al.
Published: (2023-03-01)

Using geographical information systems to identify populations in need of improved accessibility to antivenom treatment for snakebite envenoming in Costa Rica.
by: Erik Hansson, et al.
Published: (2013-01-01)

Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
by: Calvete, J, et al.
Published: (2010)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
by: Mahmood Muazu Dalhat, et al.
Published: (2023-06-01)

Clinical management of snakebite envenoming: Future perspectives
by: Muhammad Hamza, et al.
Published: (2021-09-01)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sharma, S, et al.
Published: (2019)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sanjib Kumar Sharma, et al.
Published: (2019-01-01)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana.
by: Stéphanie Houcke, et al.
Published: (2023-04-01)

Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).
by: Christopher I Johnston, et al.
Published: (2012-01-01)

Snakebite envenoming
by: Gutiérrez, J, et al.
Published: (2017)

River dataset as a potential fluvial transportation network for healthcare access in the Amazon region
by: Thiago Augusto Hernandes Rocha, et al.
Published: (2023-04-01)

Perspectives on snakebite envenoming care needs across different sociocultural contexts and health systems: A comparative qualitative analysis among US and Brazilian health providers
by: Eleanor Strand, et al.
Published: (2023-03-01)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
by: Alirol, E, et al.
Published: (2017)

Target product profiles for pan-Africa recombinant antivenoms against neurotoxic or hemotoxic and cytotoxic snakebite envenoming.
by: Andreas H Laustsen, et al.
Published: (2025-01-01)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
by: Emilie Alirol, et al.
Published: (2017-05-01)

Providing Antivenom Treatment Access to All Brazilian Amazon Indigenous Areas: ‘Every Life has Equal Value’
by: Wuelton Marcelo Monteiro, et al.
Published: (2020-12-01)

Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: An open randomized controlled phase IIb clinical trial.
by: Iran Mendonça-da-Silva, et al.
Published: (2017-11-01)

Pregnancy outcomes after snakebite envenomations: A retrospective cohort in the Brazilian Amazonia.
by: Thaís P Nascimento, et al.
Published: (2022-12-01)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
by: Nathorn Chaiyakunapruk, et al.
Published: (2022-03-01)

Integrating lay knowledge and practice into snakebite prevention and care in central Africa, a hotspot for envenomation
by: Romain Duda, et al.
Published: (2021-09-01)

Antibodies as Snakebite Antivenoms: Past and Future
by: Wilmar Dias da Silva, et al.
Published: (2022-09-01)

An investigation of snakebite antivenom usage in Taiwan
by: Chih-Chuan Lin, et al.
Published: (2016-08-01)